For the Quarter Ending June 2026
Amphotericin B Prices in North America
- In USA, the Amphotericin B Price Index rose by 0.27% quarter-over-quarter, reflecting marginal cost-push pressures.
- The average Amphotericin B price for the quarter was approximately USD 651896.67/MT, reflecting marginal logistics and compliance cost pass-through.
- Amphotericin B Spot Price remained pressured by elevated container and air freight and packaging cost increases.
- Amphotericin B Price Forecast indicates modest near-term variability driven by freight volatility and supplier offer discipline.
- Amphotericin B Production Cost Trend shows higher logistics, sterile-vial and compliance costs supporting origin offer levels.
- Amphotericin B Demand Outlook remained stable with hospital utilization steady and selective formulary shifts toward liposomal forms.
- Amphotericin B Price Index reflected importer bargaining strength amid adequate import arrivals and built inventories drawn down.
- Amphotericin B Price Index movement was moderated by currency stability and aggressive spot discounting from Indian suppliers.
Why did the price of Amphotericin B change in June 2026 in North America?
- Elevated container and air freight increased landed costs despite limited pass-through by aggressive supplier discounts.
- Built inventories from April reduced spot purchasing, weakening importers curiosity and exerting downward pricing pressure.
- Indian rupee depreciation and resumed exports increased available volumes, enabling exporters to trim dollar offers.
Amphotericin B Prices in APAC
- In China, the Amphotericin B Price Index rose by 0.26% quarter-over-quarter, reflecting marginal cost pass-through.
- The average Amphotericin B price for the quarter was approximately USD 651666.67/MT based on FOB Shanghai totals.
- Amphotericin B Spot Price remained subdued as Shanghai export inventories edged up, reducing urgency among international buyers.
- Amphotericin B Price Forecast signals modest recovery later in year as export restocking and seasonal procurement increase.
- Amphotericin B Production Cost Trend showed stability due to flat glucose and soybean peptone input pricing.
- Amphotericin B Demand Outlook remains muted short-term with hospital tender pauses and cautious overseas buying patterns.
- Amphotericin B Price Index volatility was exceptionally low, reflecting balanced supply and steady manufacturing operating rates.
- Port congestion risks and Middle-East conflict could elevate insurance premia, indirectly supporting Amphotericin B Spot Price resilience.
Why did the price of Amphotericin B change in June 2026 in APAC?
- Steady production rates across Chinese fermentation plants maintained supply, limiting upward price momentum in June.
- Adequate pharmaceutical-grade glucose and soybean peptone availability kept production costs stable, reducing cost-push inflation pressure.
- Muted hospital tender calendar and softer export enquiries lowered buying urgency, marginally pressuring spot quotations.
India
- In India, the Amphotericin B Price Index rose by 1.97% quarter-over-quarter, reflecting tighter import balance.
- Amphotericin B Spot Price pushed the Price Index higher as import delays tightened bulk availability.
Amphotericin B Prices in Europe
- In Germany, the Amphotericin B Price Index rose by 0.26% quarter-over-quarter, fueled by energy and offers.
- The average Amphotericin B price for the quarter was approximately USD 651810/MT, reported CFR Hamburg.
- Amphotericin B Spot Price softened in June as steady imports reduced spot premia among distributors.
- Amphotericin B Price Forecast indicates mild volatility driven by freight and disciplined Asian exporter pricing.
- Amphotericin B Production Cost Trend eased as natural gas and fermentation input prices declined regionally.
- Amphotericin B Demand Outlook steady as hospital procurement continues, liposomal alternatives limit conventional volume growth.
- Amphotericin B Price Index supported by balanced inventories and four to six week Hamburg coverage.
- Export demand muted; EU GMP testing and compliance increased lead times and modest landed costs.
Why did the price of Amphotericin B change in June 2026 in Europe?
- High European energy costs elevated producer offers, adding marginal landed-cost pressure for CFR Hamburg shipments.
- Diversified imports from Italy, Denmark, Spain and India eased shortages, lowering spot premiums and urgency.
- Euro weakness versus the US dollar increased landed-cost sensitivity, offsetting supplier pass-throughs to German buyers.
For the Quarter Ending March 2026
Amphotericin B Prices in APAC
- In China, the Amphotericin B Price Index rose by 0.10% quarter-over-quarter, reflecting balanced supply modest exports.
- The average Amphotericin B price for the quarter was approximately USD 650000/MT FOB Shanghai basis.
- Amphotericin B Spot Price firmed as larger exporters absorbed reallocated volumes from constrained smaller fermenters.
- Amphotericin B Production Cost Trend rose on higher substrate prices and electricity tariffs affecting freeze-drying.
- Amphotericin B Demand Outlook is steady because routine hospital off-take and export tenders maintain consumption.
- Amphotericin B Price Forecast shows mild firmness ahead as inventories tighten and buyers secure shipments.
- Amphotericin B Price Index reflected thinner on-hand stocks and disciplined seller offers from vertically-integrated manufacturers.
- Ports operated; Amphotericin B Spot Price volatility remained limited by vessel coordination and terminal stocks.
Why did the price of Amphotericin B change in March 2026 in APAC?
- Environmental inspections intensified, constraining smaller producers' batches and redirecting orders to higher-priced integrated manufacturers thereby.
- Upstream substrate and electricity costs increased, raising Amphotericin B Production Cost Trend, pressuring margins thereby.
- Export enquiries from India and Brazil absorbed output, tightening inventories, supporting Amphotericin B Price Index.
Amphotericin B Prices in Europe
- In Germany, the Amphotericin B Price Index rose by 0.11% quarter-over-quarter, reflecting marginal supply tightness.
- The average Amphotericin B price for the quarter was approximately USD 650114.67/MT, according to trade sources.
- Amphotericin B Spot Price edged higher as air-freight delays constrained prompt cargoes, supporting the Price Index.
- Amphotericin B Price Forecast points to firmness amid elevated tariffs and Amphotericin B Production Cost Trend increases.
- Amphotericin B Demand Outlook stays muted as hospitals maintain contract call-offs, limiting spot market response this quarter.
- Inventories at distributors tightened near lower three-month range, influencing Amphotericin B Production Cost Trend and import parity.
- Export offers from Italy, Denmark and India firmed, elevating Amphotericin B Spot Price and the Price Index.
- Contractual procurement and price-inelastic hospital demand limited speculative buying, moderating Amphotericin B Price Index volatility.
Why did the price of Amphotericin B change in March 2026 in Europe?
- Elevated utility tariffs and stricter GMP compliance increased manufacturing costs, prompting producers to lift dollar offers.
- Lengthened temperature-controlled air-freight lead-times tightened prompt availability, raising reliance on higher-cost shipments and insurance premiums.
- Hospital procurement stayed price-inelastic with stable tenders, limiting demand response despite marginal import cost pressures.
Amphotericin B Prices in North America
- In the USA, the Amphotericin B Price Index rose by 0.11% quarter-over-quarter, reflecting balanced imports.
- The average Amphotericin B price for the quarter was approximately USD 650,156.67/MT, from importer transactions.
- Amphotericin B Spot Price tightened in March as freight rose, lifting the Price Index modestly.
- Amphotericin B Price Forecast shows modest gains driven by higher logistics and steady hospital demand.
- Amphotericin B Production Cost Trend remained stable for fermentation inputs, though logistics raised landed costs.
- Amphotericin B Demand Outlook stable as hospitals held contracted volumes, keeping spot buying subdued throughout.
- Distributor inventories remained lean and export allocations limited, supporting the Amphotericin B Price Index strength.
- Exporters operated with routine maintenance trimming slots, influencing Amphotericin B Spot Price and CFR offers.
Why did the price of Amphotericin B change in March 2026 in North America?
- Rising trans-Pacific freight in March increased landed costs for imported Amphotericin B, applying upward pressure.
- Steady export production but cautious batch releases trimmed available volumes, tightening supply for U.S. distributors.
- Hospital procurement remained firm due to clinical need and contract cycles, limiting downward price momentum.
For the Quarter Ending December 2025
Amphotericin B Prices in North America
- In USA, the Amphotericin B Price Index rose by 0.56% quarter-over-quarter, reflecting constrained supply pressures.
- The average Amphotericin B price for the quarter was USD 649446.67/MT on CFR Houston basis.
- Amphotericin B Spot Price firmed as Indian exporters limited shipments after sterility re-tests reduced volumes.
- Amphotericin B Price Forecast suggests modest gains from import constraints and institutional purchasing demand support.
- Amphotericin B Production Cost Trend edged higher as sterile processing and precursor materials pushed prices.
- Amphotericin B Demand Outlook firm as hospitals and formulators replenish stocks ahead of seasonal pressures.
- Amphotericin B Price Index advanced despite lower ocean freight, because cold-chain air transport remained costly.
- Domestic fermentation plants operated normally, covering one-third of demand, sustaining import dependence and price resilience.
Why did the price of Amphotericin B change in December 2025 in North America?
- Reduced Indian export volumes after batch re-tests tightened spot availability, nudging CFR Houston prices higher.
- Cold-chain airfreight costs stayed elevated despite falling ocean rates, limiting full logistical relief for imports.
- Sustained hospital demand and distributor restocking ahead of winter supported modest Amphotericin B price increases.
Amphotericin B Prices in APAC
- In China, the Amphotericin B Price Index rose by 0.52% quarter-over-quarter, driven by tighter supply.
- The average Amphotericin B price for the quarter was approximately USD 649333.33/MT, weighted shipment average.
- Stable factory runs supported Amphotericin B Spot Price stability, while freight prevented deeper downward adjustment.
- Inventory drawdowns at formulators tightened the Amphotericin B Price Index, reducing availability for urgent orders.
- Export demand remained routine, shaping the Amphotericin B Demand Outlook as modest and broadly stable.
- Higher feedstock, freight costs nudged the Amphotericin B Production Cost Trend upward, supporting seller margins.
- Analysts expect the Amphotericin B Price Forecast to show upticks amid freight volatility, scheduled maintenance.
- Domestic plant reliability and steady hospital procurement kept the Amphotericin B Price Index broadly balanced.
Why did the price of Amphotericin B change in December 2025 in APAC?
- Intermittent factory downtime and flooding constrained intermediate feedstock supply, tightening amphotericin availability for December shipments.
- Air freight surges and mid-quarter GRIs raised logistics costs, prompting producers to protect margins modestly.
- Steady hospital procurement and routine export orders maintained demand, preventing sharp volatility despite cost pressures.
Amphotericin B Prices in Europe
- In Germany, the Amphotericin B Price Index rose by 0.51% quarter-over-quarter, reflecting tightened imports and logistics pressures.
- The average Amphotericin B price for the quarter was approximately USD 649411.67/MT, reported by trade sources.
- Amphotericin B Spot Price remained firm in December as import offers reflected elevated energy and compliance costs.
- Amphotericin B Price Forecast indicates modest, steady appreciation supported by seasonal restocking and manageable logistical constraints.
- Amphotericin B Production Cost Trend shows upward pressure from higher electricity tariffs and testing compliance expenses.
- Amphotericin B Demand Outlook remains stable as hospitals follow tenders, limiting discretionary procurement and volume growth.
- Amphotericin B Price Index movement was tempered by steady inventories and import schedules from Italy, Denmark, and India.
- Exports from Southern Europe and Asia operated normally, keeping landed costs stable while modest replacement-cost pass-through persisted.
Why did the price of Amphotericin B change in December 2025 in Europe?
- Import tightening and re-routing raised landed costs, reducing readily available surplus cargo in the German market.
- Higher electricity tariffs and GMP testing compliance increased production and replacement costs for imported Amphotericin B.
- Seasonal hospital restocking and cautious forward procurement absorbed surplus stocks, supporting modest upward price momentum.
For the Quarter Ending September 2025
North America
- In the USA, the Amphotericin B Price Index rose by 0.25% quarter-over-quarter, due to frontloading.
- The average Amphotericin B price for the quarter was approximately USD 645802/MT, reported by sources.
- Accelerated imports tightened inventory, supported the Amphotericin B Spot Price, reducing availability across distribution channels.
- Rising handling and shipping expenses influenced the Amphotericin B Production Cost Trend, pressuring supplier margins.
- Forward procurement concentrated purchases, shaping the Amphotericin B Demand Outlook and sustaining near term prices.
- Manufacturer release pacing with cautious distributor stocking tempered the Amphotericin B Price Index and volatility.
- Models and steady import activity inform the Amphotericin B Price Forecast, indicating modest upward adjustments.
- Container rate increases and port congestion raised costs, affecting Amphotericin B supply chains and margins.
Why did the price of Amphotericin B change in September 2025 in North America?
- Advanced buying ahead of tariff uncertainty increased near-term demand, tightening available inventories and pressuring prices.
- Inflationary pressures and elevated logistics handling costs raised production, distribution costs, supporting modest price increases.
- Ports experienced congestion and container cost upticks, slowing flows and prompting procurement to secure supply.
APAC
- In China, the Amphotericin B Price Index rose by 0.30% quarter-over-quarter, led by export frontloading.
- The average Amphotericin B price for the quarter was approximately USD 646000.00/MT, reflecting modest export-led firming.
- Amphotericin B Spot Price subdued as suppliers tightened availability while Amphotericin B Price Index steadied.
- The Amphotericin B Price Forecast indicates modest gains amid logistical cost increases and producer discipline.
- Amphotericin B Production Cost Trend reflects higher freight and weather costs, mildly pressuring producer margins.
- Amphotericin B Demand Outlook is cautiously positive due to export restocking and steady downstream formulation.
- Exports and constrained vessel space tightened availability, prompting firms to prioritize contractual shipments over spot sales.
- Major exporters maintained measured operating rates, keeping inventories balanced and limiting price volatility into the season.
Why did the price of Amphotericin B change in September 2025 in APAC?
- Frontloaded export shipments ahead of tariff suspension increased demand, tightening supply and supporting price rises.
- Rising ocean freight and weather disruptions elevated production costs, exerting upward pressure on domestic pricing.
- Manufacturers maintained cautious operating rates and inventory discipline, moderating supply responses and stabilizing the market.
Europe
- In Germany, the Amphotericin B Price Index rose by 0.30% quarter-over-quarter, driven by port congestion.
- The average Amphotericin B price for the quarter was approximately USD 646094.33/MT on CFR Hamburg.
- Supply tightness and early restocking kept Amphotericin B Spot Price supported despite freight cost increases.
- Amphotericin B Price Index stability reflected managed logistics, modest surcharges, and disciplined distributor procurement behavior.
- Amphotericin B Price Forecast shows gradual modest increases projected through Q4, assuming logistics steadily normalize.
- Amphotericin B Production Cost Trend saw upward pressure from higher freight and inland transport costs.
- Amphotericin B Demand Outlook remains steady as hospitals and wholesalers cautiously restock, avoiding bulk purchases.
- Inventory drawdowns and constrained imports limited spot availability, supporting the short-term Amphotericin B market equilibrium.
Why did the price of Amphotericin B change in September 2025 in Europe?
- Port congestion and inland transport constraints delayed shipments, tightening supply and increasing procurement uncertainties premiums.
- Rerouted shipping and higher freight increased landed costs significantly, exerting upward pressure on market offers.
- Buyers preemptively restocked amid uncertain delivery schedules, reducing available spot volumes and supporting modest increases.
